BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2001
View Archived Issues
Health Canada approves Pantoloc for treatment of heartburn
Read More
Pharmacopeia and Mitsubishi-Tokyo establish new drug discovery collaboration
Read More
Medarex and Schering-Plough to develop human antibody therapeutics
Read More
Novel cardiovascular drugs sought by MediGene and Evotec BioSystems
Read More
NCI confirms antitumor activity of microalgae-derived Aquasearch compound
Read More
ACAT inhibitor originating in Japan advances through U.S. clinical trials
Read More
Next stage of clinical trials of oxaliplatin begins in Japan
Read More
Novartis, GeneData establish antimicrobial drug development alliance
Read More
Comprehensive review of Natrecor published in prestigious journal
Read More
Structure-based design of nonthiazolidinedione PPARgamma antagonists
Read More
Cinnamide-based LFA-1/ICAM-1 antagonists with improved properties presented at ACS meeting
Read More
Preclinical studies further explore antiangiogenic effects of squalamine
Read More
Biomira to pursue cancer vaccine development on its own
Read More
DepoCyte recommended for approval by CPMP
Read More
Potential of halofuginone in cancer therapy highlighted in AACR presentation
Read More
Valcyte approved by FDA for AIDS-related CMV
Read More
PNU-177684: discovery of a clinical antipsychotic candidate and selective D3 antagonist
Read More
Ortec seeks FDA approval to market wound-healing product in burn patients
Read More
Replacement of benzamidine with azaindole in Aventis series provides oral factor Xa inhibitors
Read More
Pharmos reports update on major products
Read More
ACS news: Sch-211803, a potent and highly selective M2 antagonist selected for clinical development
Read More
Timing of M-Vax administration crucial for survival and immunological outcomes
Read More
Improved paclitaxel derivatives in development at The Liposome Company
Read More
Novel aromatic amidine derivatives from Toa Eiyo useful as antithrombotic agents
Read More
Metabotropic glutamate receptor antagonists in development at NPS
Read More
Senju prepares new chymase inhibitor series for use in cardiovascular disorders
Read More
JNK inhibitors designed and tested at Signal
Read More
AstraZeneca presents newest series of PPARgamma activators in recent patent
Read More
Recently issued international patent describes compounds for neurodegenerative disorders
Read More